Current status of intravenous tissue plasminogen activator dosage for acute ischaemic stroke: an updated systematic review

The optimal dose of recombinant tissue plasminogen activator (rtPA) for acute ischaemic stroke (AIS) remains controversial, especially in Asian countries. We aimed to update the evidence regarding the use of low-dose versus standard-dose rtPA. We performed a systematic literature search across MEDLI...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Stroke Vasc Neurol
Main Authors: Wang, Xia, You, Shoujiang, Sato, Shoichiro, Yang, Jie, Carcel, Cheryl, Zheng, Danni, Yoshimura, Sohei, Anderson, Craig S, Sandset, Else Charlotte, Robinson, Thompson, Chalmers, John, Sharma, Vijay K
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2018
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5870642/
https://ncbi.nlm.nih.gov/pubmed/29600005
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/svn-2017-000112
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados